Signature Diagnostics GmbH logo — company profile

Signature Diagnostics GmbH

Founded 2004 Series C Total: $5.10M Biotechnology, Health Care

General Information

Company Name Signature Diagnostics GmbH
Founded Year 2004
Industries Biotechnology, Health Care
Funding Stage Series C
Social

Get notified when Signature Diagnostics GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Signature Diagnostics GmbH

Signature Diagnostics AG, established in 2004 and located in Potsdam, Germany, specializes in translational oncology and genomics. The company constructs expansive tumor tissue and plasma biobanks for various cancers, including colorectal and lung cancer, through extensive multicenter prospective clinical trials. Central to their oncology research are biobanks with longitudinal plasma samples from cancer patients. Additionally, Signature develops several next generation sequencing (NGS) assays using targeted gene panels and possesses expertise in creating ultra-deep sequencing tests using cfDNA, which may enhance non-invasive treatment response monitoring for cancer patients. The company received a €5.10M Series C investment at 12 August 2008 from a group of investors including KfW, BFB Fruehphasenfonds, EVP Capital Management, OncoMethylome, and GoodVent Beteiligungsmanagement. With a strong focus on leveraging genomics for cancer research and treatment, Signature Diagnostics presents an appealing investment opportunity in the biotechnology and healthcare industries.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 5
Investor Investor
•••• ••••
12 Aug 2008
Series B •••••• 1 •••• •••• 30 Jan 2008
Grant •••••• - 04 Mar 2005

Signature Diagnostics GmbH Alternatives & Competitors

Signature Diagnostics GmbH vs

Redefining Precision Oncology

16 employees
Signature Diagnostics GmbH vs
Function
Function United States

Personalized functional genomics transforming the future of cancer

Series A
7 employees
Biotechnology, Health and Wellness
Signature Diagnostics GmbH vs

Precision Oncology Specialists: Science and Support for All Things Cancer

11 employees

FAQ About Signature Diagnostics GmbH

Signature Diagnostics AG, established in 2004 and located in Potsdam, Germany, specializes in translational oncology and genomics. The company constructs expansive tumor tissue and plasma biobanks for various cancers, including colorectal and lung cancer, through extensive multicenter prospective cl...
Signature Diagnostics GmbH was founded in 2004.
Signature Diagnostics GmbH operates in the following industries: Biotechnology, Health Care.
Signature Diagnostics GmbH has completed 3 funding rounds, raising a total of $5.10M. The latest funding stage is Series C.
Top alternatives and competitors to Signature Diagnostics GmbH include Pangea Biomed, Function, CTOAM | Cancer Treatment Options & Management, Massive Bio, BIOMAKERS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Signature Diagnostics GmbH and Pangea Biomed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Signature Diagnostics GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes